CommentSecond primary cancers in survivors of childhood cancer
References (16)
- et al.
Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries
J Natl Cancer Inst
(2009) - et al.
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study
J Natl Cancer Inst
(2001) - et al.
Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain
Br J Cancer
(2004) - et al.
Second cancers in survivors of childhood cancer
Nat Rev Cancer
(2002) - et al.
Pharmacogenomics—drug disposition, drug targets, and side effects
N Engl J Med
(2003) - et al.
Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review
J Natl Cancer Inst
(2000) - et al.
Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study
J Natl Cancer Inst
(2008) - et al.
Chronic health conditions in adult survivors of childhood cancer
N Engl J Med
(2006)
Cited by (33)
Cancer screening in the pediatric cancer patient: a focus on genitourinary malignancies, and why does a urologist need to know about this?
2019, Journal of Pediatric UrologyCitation Excerpt :The reasons for non-compliance are predominantly focused on five major points. They are inadequate education of the patient, inadequate education of the physician, insufficient interphysician communication, the patient's fiscal constraints, and the decreased cognition of the patient that may develop as a consequence of chemoradiation therapy [9,11,13,14,18]. The purpose of this article is the education of the physician to recognize the high-risk patient who should be recommended for follow-up for cancer surveillance.
GH deficiency in adult survivors of childhood cancer
2016, Best Practice and Research: Clinical Endocrinology and MetabolismCitation Excerpt :In CCS treated with GH, the first concern regards the increased risk of disease recurrence. The second one is the supposed effect of GH administration on the development of SNs, which represents one of the most feared late complication of anticancer treatments [46–48]. In the 2000s Swerdlow et al. evaluated 180 CCS with brain tumor treated with GH between 1965 and 1996.
Ultrasound surveillance for radiation-induced thyroid carcinoma in adult survivors of childhood cancer
2016, European Journal of CancerHealthcare Expenditure Burden among Non-elderly Cancer Survivors, 2008-2012
2015, American Journal of Preventive MedicineAccess to preventive health care for cancer survivors
2013, American Journal of Preventive Medicine